BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10757034)

  • 1. Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased.
    Heidari S; Berke Z; Berglöf A; Woldegiorgis A; Smith CI; Dalianis T
    In Vivo; 1999; 13(6):439-44. PubMed ID: 10757034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult X-linked immunodeficiency (XID) mice, IGM-/- single knockout and IGM-/- CD8-/- double knockout mice do not clear polyomavirus infection.
    Berke Z; Mellin H; Heidari S; Wen T; Berglöf A; Klein G; Dalianis T
    In Vivo; 1998; 12(2):143-8. PubMed ID: 9627794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis.
    Drake DR; Lukacher AE
    Virology; 1998 Dec; 252(1):275-84. PubMed ID: 9875336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.
    Szomolanyi-Tsuda E; Brien JD; Dorgan JE; Garcea RL; Woodland RT; Welsh RM
    Virology; 2001 Feb; 280(2):160-8. PubMed ID: 11162830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B lymphocyte production in the bone marrow of mice with X-linked immunodeficiency (xid).
    Reid GK; Osmond DG
    J Immunol; 1985 Oct; 135(4):2299-302. PubMed ID: 3875649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of congenitally immunologic mutant New Zealand mice. VI. Spontaneous and induced autoantibodies to red cells and DNA occur in New Zealand X-linked immunodeficient (Xid) mice without phenotypic alternations of the Xid gene or generalized polyclonal B cell activation.
    Ohsugi Y; Gershwin ME; Ahmed A; Skelly RR; Milich DR
    J Immunol; 1982 May; 128(5):2220-7. PubMed ID: 6977588
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody response is required for protection from Theiler's virus-induced encephalitis in C57BL/6 mice in the absence of CD8+ T cells.
    Kang BS; Palma JP; Lyman MA; Dal Canto M; Kim BS
    Virology; 2005 Sep; 340(1):84-94. PubMed ID: 16039687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice.
    Compton SR; Ball-Goodrich LJ; Johnson LK; Johnson EA; Paturzo FX; Macy JD
    Comp Med; 2004 Dec; 54(6):681-9. PubMed ID: 15679267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
    Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
    J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autologous mixed lymphocyte response: delayed T cell tolerance to B cells in XID mice.
    Riggs JE; Maurio FP; Prior LG; Sirken GR; Hobbs MV
    Cell Immunol; 1994 Sep; 157(2):542-8. PubMed ID: 7915205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells.
    Moser JM; Altman JD; Lukacher AE
    J Exp Med; 2001 Mar; 193(5):595-606. PubMed ID: 11238590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low natural antibody and low in vivo tumor resistance, in xid-bearing B-cell deficient mice.
    Chow DA; Bennet RD
    J Immunol; 1989 May; 142(10):3702-6. PubMed ID: 2785560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor development after polyoma infection in athymic nude mice.
    Stutman
    J Immunol; 1975 Apr; 114(4):1213-7. PubMed ID: 163861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hypersensitivity to polyoma and "self" antigens in syngeneic mice.
    Ochałek T; Burzyński A; Cadel Z; Chłap Z; Porwit-Bóbr Z
    Neoplasma; 1987; 34(4):441-51. PubMed ID: 2821418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoma tumor development in neonatally polyoma-virus-infected CD4-/- and CD8-/- single knockout and CD4-/-8-/- double knockout mice.
    Berke Z; Wen T; Klein G; Dalianis T
    Int J Cancer; 1996 Jul; 67(3):405-8. PubMed ID: 8707416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the immune response against a polyoma virus-induced fibrosarcoma in BALB mice using the Winn's tumor neutralization assay.
    de Lapeyrière O; Imbert J; Cot E; Meyer G
    Bull Cancer; 1981; 68(2):101-8. PubMed ID: 6263382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic polymerase chain reaction assays for identification of murine polyomaviruses in biological samples.
    Carty AJ; Franklin CL; Riley LK; Besch-Williford C
    Comp Med; 2001 Apr; 51(2):145-9. PubMed ID: 11922178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to polyoma virus infection and tumorigenesis.
    Moser JM; Lukacher AE
    Viral Immunol; 2001; 14(3):199-216. PubMed ID: 11572632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.
    Moser JM; Gibbs J; Jensen PE; Lukacher AE
    Nat Immunol; 2002 Feb; 3(2):189-95. PubMed ID: 11812997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The art of survival during viral persistence.
    Stohlman SA; Ramakrishna C; Tschen SI; Hinton DR; Bergmann CC
    J Neurovirol; 2002 Dec; 8 Suppl 2():53-8. PubMed ID: 12491152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.